Joelle Desfossés

Endocannabinoids and Schizophrenia

E. Stip, S. Potvin, L. Bentaleb, 2010, Pharmaceuticals.

Predictors of Community Functioning in Schizophrenia and Substance Use Disorder Patients

E. Stip, T. Pampoulova, S. Potvin, 2013, Community Mental Health Journal.

Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia

E. Stip, S. Potvin, L. Bentaleb, 2012, Front. Psychiatry.

Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case–Control Trial with Quetiapine

P. Rompré, E. Stip, T. Pampoulova, 2011, Front. Psychiatry.